Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer

Clinical trial NCT01684397 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT01684397
Sponsor: Roswell Park Cancer Institute
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Clear Cell Renal Cell Carcinoma Stage IV Renal Cell Cancer

Start date: 2012-11-21
Primary completion: 2026-08-20
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.